In a twist of events, a Delaware federal judge on Tuesday effectively overturned a 2022 jury verdict pertaining to a medical device patent dispute between Kurin Inc. and Magnolia Medical Technologies Inc. The contentious patent, belonging to Magnolia, revolves around sepsis testing
The jury had previously determined that Kurin Inc. had infringed upon this patent, subsequently ordering the company to pay $2 million in damages to Magnolia. However, Tuesday’s ruling contravenes this decision, ruling in favor of Kurin. The judge found that Kurin did not, in fact, infringe upon Magnolia’s sepsis testing patent claims.
For more intricate details on the ruling and its implications, interested readers may refer to the report on Law360.